Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ITOS |
---|---|---|
09:32 ET | 220 | 13.4 |
09:34 ET | 1271 | 13.35 |
09:36 ET | 392 | 13.4 |
09:39 ET | 2371 | 13.05 |
09:41 ET | 800 | 13.14 |
09:43 ET | 100 | 13.145 |
09:50 ET | 600 | 13.11 |
09:52 ET | 394 | 13.11 |
09:54 ET | 1250 | 13.03 |
09:56 ET | 1725 | 12.97 |
09:57 ET | 300 | 13.06 |
09:59 ET | 700 | 13 |
10:01 ET | 1215 | 13.08 |
10:06 ET | 1084 | 13.05 |
10:10 ET | 2561 | 12.91 |
10:12 ET | 300 | 12.94 |
10:14 ET | 1855 | 12.83 |
10:15 ET | 500 | 12.87 |
10:17 ET | 1158 | 12.89 |
10:19 ET | 7661 | 13.02 |
10:21 ET | 100 | 13.01 |
10:26 ET | 250 | 13.19 |
10:30 ET | 927 | 13.15 |
10:33 ET | 490 | 13.2 |
10:35 ET | 700 | 13.3 |
10:37 ET | 1315 | 13.29 |
10:39 ET | 946 | 13.37 |
10:42 ET | 350 | 13.32 |
10:44 ET | 750 | 13.34 |
10:46 ET | 575 | 13.3696 |
10:50 ET | 900 | 13.46 |
10:53 ET | 850 | 13.44 |
10:55 ET | 700 | 13.38 |
10:57 ET | 2100 | 13.39 |
11:02 ET | 200 | 13.34 |
11:04 ET | 2476 | 13.21 |
11:08 ET | 200 | 13.25 |
11:09 ET | 813 | 13.21 |
11:11 ET | 227 | 13.2095 |
11:13 ET | 2500 | 13.1975 |
11:15 ET | 1150 | 13.21 |
11:18 ET | 727 | 13.29 |
11:22 ET | 350 | 13.32 |
11:24 ET | 325 | 13.315 |
11:26 ET | 1416 | 13.33 |
11:27 ET | 100 | 13.31 |
11:29 ET | 475 | 13.35 |
11:31 ET | 100 | 13.36 |
11:33 ET | 200 | 13.34 |
11:36 ET | 300 | 13.3 |
11:38 ET | 350 | 13.26 |
11:40 ET | 1065 | 13.33 |
11:42 ET | 480 | 13.355 |
11:44 ET | 5492 | 13.37 |
11:45 ET | 1000 | 13.375 |
11:47 ET | 1500 | 13.35 |
11:49 ET | 2000 | 13.399 |
11:51 ET | 100 | 13.31 |
11:54 ET | 960 | 13.38 |
11:58 ET | 200 | 13.35 |
12:00 ET | 1080 | 13.4 |
12:02 ET | 362 | 13.42 |
12:03 ET | 2600 | 13.4263 |
12:05 ET | 1100 | 13.43 |
12:07 ET | 4531 | 13.455 |
12:14 ET | 100 | 13.455 |
12:16 ET | 228 | 13.455 |
12:18 ET | 200 | 13.455 |
12:20 ET | 423 | 13.455 |
12:23 ET | 2700 | 13.48 |
12:25 ET | 597 | 13.475 |
12:27 ET | 148 | 13.5128 |
12:30 ET | 250 | 13.515 |
12:32 ET | 400 | 13.53 |
12:34 ET | 670 | 13.5 |
12:36 ET | 900 | 13.495 |
12:38 ET | 1400 | 13.51 |
12:43 ET | 1071 | 13.5 |
12:45 ET | 100 | 13.49 |
12:50 ET | 750 | 13.535 |
12:52 ET | 1068 | 13.59 |
12:54 ET | 1871 | 13.57 |
12:56 ET | 1200 | 13.62 |
12:59 ET | 606 | 13.6 |
01:01 ET | 304 | 13.63 |
01:03 ET | 6927 | 13.57 |
01:06 ET | 1124 | 13.5594 |
01:08 ET | 1103 | 13.53 |
01:10 ET | 5040 | 13.5 |
01:12 ET | 5654 | 13.48 |
01:14 ET | 9045 | 13.5285 |
01:15 ET | 100 | 13.52 |
01:17 ET | 200 | 13.51 |
01:19 ET | 409 | 13.53 |
01:24 ET | 900 | 13.535 |
01:26 ET | 1103 | 13.56 |
01:28 ET | 200 | 13.58 |
01:30 ET | 1170 | 13.58 |
01:32 ET | 300 | 13.5652 |
01:33 ET | 110 | 13.575 |
01:35 ET | 346 | 13.54 |
01:37 ET | 966 | 13.515 |
01:39 ET | 3100 | 13.475 |
01:42 ET | 400 | 13.5 |
01:44 ET | 24435 | 13.46 |
01:46 ET | 1269 | 13.46 |
01:48 ET | 1438 | 13.475 |
01:51 ET | 705 | 13.5 |
01:57 ET | 299 | 13.49 |
02:00 ET | 100 | 13.52 |
02:02 ET | 300 | 13.6 |
02:04 ET | 5865 | 13.505 |
02:06 ET | 100 | 13.51 |
02:08 ET | 401 | 13.6 |
02:09 ET | 351 | 13.64 |
02:11 ET | 447 | 13.61 |
02:13 ET | 687 | 13.6347 |
02:15 ET | 135 | 13.63 |
02:18 ET | 500 | 13.64 |
02:20 ET | 791 | 13.65 |
02:22 ET | 1700 | 13.65 |
02:24 ET | 600 | 13.674 |
02:26 ET | 100 | 13.63 |
02:27 ET | 611 | 13.65 |
02:31 ET | 977 | 13.6505 |
02:33 ET | 899 | 13.68 |
02:38 ET | 600 | 13.66 |
02:42 ET | 200 | 13.61 |
02:44 ET | 2289 | 13.59 |
02:45 ET | 1620 | 13.56 |
02:47 ET | 100 | 13.53 |
02:49 ET | 287 | 13.5 |
02:54 ET | 100 | 13.5 |
02:56 ET | 3895 | 13.55 |
02:58 ET | 800 | 13.555 |
03:00 ET | 407 | 13.565 |
03:02 ET | 1100 | 13.5575 |
03:03 ET | 1288 | 13.5206 |
03:05 ET | 1927 | 13.51 |
03:07 ET | 486 | 13.53 |
03:09 ET | 1900 | 13.51 |
03:12 ET | 200 | 13.51 |
03:14 ET | 745 | 13.54 |
03:16 ET | 400 | 13.525 |
03:18 ET | 502 | 13.54 |
03:20 ET | 400 | 13.52 |
03:21 ET | 100 | 13.52 |
03:23 ET | 1347 | 13.54 |
03:25 ET | 218 | 13.54 |
03:27 ET | 700 | 13.55 |
03:30 ET | 100 | 13.54 |
03:32 ET | 515 | 13.52 |
03:34 ET | 379 | 13.503 |
03:36 ET | 200 | 13.52 |
03:38 ET | 800 | 13.53 |
03:39 ET | 2973 | 13.5388 |
03:41 ET | 100 | 13.54 |
03:43 ET | 1900 | 13.54 |
03:45 ET | 1254 | 13.5499 |
03:48 ET | 1121 | 13.505 |
03:50 ET | 1438 | 13.55 |
03:52 ET | 1135 | 13.58 |
03:54 ET | 2238 | 13.66 |
03:56 ET | 2290 | 13.64 |
03:57 ET | 2368 | 13.66 |
03:59 ET | 45927 | 13.64 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Iteos Therapeutics Inc | 488.9M | -4.3x | --- |
Arbutus Biopharma Corp | 463.1M | -5.9x | --- |
Taysha Gene Therapies Inc | 536.7M | -2.1x | --- |
Invivyd Inc | 488.9M | -2.9x | --- |
Oculis Holding AG | 442.7M | 0.0x | --- |
Larimar Therapeutics Inc | 484.2M | -9.0x | --- |
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways. Its lead antibody product candidate, belrestotug, also known as EOS-448/GSK4428859A, is an antagonist of TIGIT, an immune checkpoint with multiple mechanisms of action. Its advanced program is inupadenant, also known as EOS-850, a next-generation adenosine 2A receptor (A2AR) antagonist tailored to overcome the specific adenosine-mediated immunosuppression found in the tumor microenvironment. Its program to initiate clinical trials is EOS-984, a potentially first-in-class small molecule focused on a new mechanism in the adenosine pathway by targeting equilibrative nucleoside transporter 1 (ENT1), a dominant transporter of adenosine on lymphocytes involved in T cell metabolism.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $488.9M |
---|---|
Revenue (TTM) | $12.6M |
Shares Outstanding | 35.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.19 |
EPS | $-3.15 |
Book Value | $16.05 |
P/E Ratio | -4.3x |
Price/Sales (TTM) | 38.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,198.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.